Changeflow GovPing Healthcare & Life Sciences FDA Variance Approval Letter to Dapper Rave, LLC
Routine Guidance Added Final

FDA Variance Approval Letter to Dapper Rave, LLC

Email

Summary

The Food and Drug Administration (FDA) has issued a variance approval letter to Dapper Rave, LLC, through its Center for Devices and Radiological Health (CDRH). This document signifies an approval for a specific variance requested by the company.

Published by FDA on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to Dapper Rave, LLC. This document indicates that a specific request for a variance from standard FDA regulations has been granted to the company. The exact nature of the variance and the specific regulations it pertains to are not detailed in the provided metadata, but it represents an official FDA decision on a company's request.

Compliance officers should note that this is a final, approved variance for a specific entity. While this approval is specific to Dapper Rave, LLC, it may set a precedent or provide insight into the FDA's considerations for similar requests from other entities in the future. It is advisable to review the full document if Dapper Rave, LLC operates within your organization's supply chain or if your company intends to seek similar variances.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

There are no documents available to view or download

Attachments 1

Variance Approval Letter from FDA CDRH to Dapper Rave, LLC

More Information
- Author(s) CDRH
Download

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Instrument
Guidance
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
FDA-2026-V-0876-0003
Docket
FDA-2026-V-0876-0003

Who this affects

Applies to
Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Medical Device Approval
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Compliance
Topics
Regulatory Compliance

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!